MatriSys Bioscience's Convertible Note Round

MatriSys Bioscience raised a round of funding on January 05, 2017. Investors include Tech Coast Angels.

MatriSys Bioscience (MatriSys Bio) is a clinical stage Specialty Biopharmaceutical Company focused on developing and commercializing rational microbiome therapies for the top five dermatology and skin…

Articles about MatriSys Bioscience's Convertible Note Round: